Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 1 of 2: GR values. - Dataset (ID:20364)
Download: Excel (XLSX), Comma-separated (CSV)
Cell line | Drug name | Experimental replicate | Timepoint | Drug concentration | Live cell count | Average live cell count, DMSO control | Average live cell count (time = 0) | Log10(drug concentration) | GR value | Relative cell count (treatment versus DMSO) | Cell doublings (DMSO control) | Experiment name |
---|---|---|---|---|---|---|---|---|---|---|---|---|
HCC70 | Buparlisib | 3 | 72 | 0.32 | 2363.0 | 2804.3 | 517.3 | -0.495 | 0.864 | 0.843 | 2.439 | HCC70 BKM120 0 3 72 |
HCC70 | BX-912 | 3 | 72 | 0.001 | 2803.3 | 2856.5 | 517.3 | -3.0 | 0.985 | 0.981 | 2.465 | HCC70 BX912 0 3 72 |
HCC70 | BX-912 | 3 | 72 | 0.0032 | 3057.0 | 2856.5 | 517.3 | -2.49 | 1.060 | 1.070 | 2.465 | HCC70 BX912 0 3 72 |
HCC70 | BX-912 | 3 | 72 | 0.032 | 3057.0 | 2856.5 | 517.3 | -1.49 | 1.060 | 1.070 | 2.465 | HCC70 BX912 0 3 72 |
HCC70 | BX-912 | 3 | 72 | 0.1 | 2906.5 | 2856.5 | 517.3 | -1.0 | 1.010 | 1.020 | 2.465 | HCC70 BX912 0 3 72 |
HCC70 | AS605240 | 3 | 72 | 0.001 | 2799.3 | 2821.5 | 517.3 | -3.0 | 0.994 | 0.992 | 2.447 | HCC70 AS605240 0 3 72 |
HCC70 | AS605240 | 3 | 72 | 0.0032 | 2836.0 | 2821.5 | 517.3 | -2.49 | 1.000 | 1.010 | 2.447 | HCC70 AS605240 0 3 72 |
HCC70 | AS605240 | 3 | 72 | 0.032 | 2913.0 | 2821.5 | 517.3 | -1.49 | 1.030 | 1.030 | 2.447 | HCC70 AS605240 0 3 72 |
HCC70 | AS605240 | 3 | 72 | 0.1 | 2523.0 | 2821.5 | 517.3 | -1.0 | 0.911 | 0.894 | 2.447 | HCC70 AS605240 0 3 72 |
HCC70 | AS605240 | 3 | 72 | 3.2 | 1585.8 | 2821.5 | 517.3 | 0.505 | 0.580 | 0.562 | 2.447 | HCC70 AS605240 0 3 72 |
HCC70 | AZD-6482 | 3 | 72 | 0.001 | 2842.0 | 2991.0 | 517.3 | -3.0 | 0.960 | 0.950 | 2.532 | HCC70 AZD6482 0 3 72 |
HCC70 | AZD-6482 | 3 | 72 | 0.01 | 2686.0 | 2991.0 | 517.3 | -2.0 | 0.917 | 0.898 | 2.532 | HCC70 AZD6482 0 3 72 |
HCC70 | AZD-6482 | 3 | 72 | 0.032 | 2461.0 | 2991.0 | 517.3 | -1.49 | 0.852 | 0.823 | 2.532 | HCC70 AZD6482 0 3 72 |
HCC70 | AZD-6482 | 3 | 72 | 3.2 | 1289.8 | 2991.0 | 517.3 | 0.505 | 0.435 | 0.431 | 2.532 | HCC70 AZD6482 0 3 72 |
HCC70 | AZD8055 | 3 | 72 | 0.001 | 2586.0 | 2811.8 | 517.3 | -3.0 | 0.933 | 0.920 | 2.442 | HCC70 AZD8055 0 3 72 |
HCC70 | AZD8055 | 3 | 72 | 0.01 | 2231.8 | 2811.8 | 517.3 | -2.0 | 0.819 | 0.794 | 2.442 | HCC70 AZD8055 0 3 72 |
HCC70 | AZD8055 | 3 | 72 | 0.032 | 1819.5 | 2811.8 | 517.3 | -1.49 | 0.674 | 0.647 | 2.442 | HCC70 AZD8055 0 3 72 |
HCC70 | AZD8055 | 3 | 72 | 1.0 | 1584.0 | 2811.8 | 517.3 | 0.0 | 0.581 | 0.563 | 2.442 | HCC70 AZD8055 0 3 72 |
HCC70 | AZD8055 | 3 | 72 | 3.2 | 1558.3 | 2811.8 | 517.3 | 0.505 | 0.571 | 0.554 | 2.442 | HCC70 AZD8055 0 3 72 |
HCC70 | Dactolisib | 3 | 72 | 0.0032 | 2460.5 | 2787.8 | 517.3 | -2.49 | 0.900 | 0.883 | 2.430 | HCC70 BEZ235 0 3 72 |
HCC70 | Dactolisib | 3 | 72 | 0.01 | 2127.5 | 2787.8 | 517.3 | -2.0 | 0.789 | 0.763 | 2.430 | HCC70 BEZ235 0 3 72 |
HCC70 | Dactolisib | 3 | 72 | 3.2 | 1018.0 | 2787.8 | 517.3 | 0.505 | 0.321 | 0.365 | 2.430 | HCC70 BEZ235 0 3 72 |
HCC70 | Buparlisib | 3 | 72 | 0.001 | 2755.0 | 2804.3 | 517.3 | -3.0 | 0.986 | 0.982 | 2.439 | HCC70 BKM120 0 3 72 |
HCC70 | Alpelisib | 3 | 72 | 0.0032 | 2887.5 | 2855.8 | 517.3 | -2.49 | 1.010 | 1.010 | 2.465 | HCC70 BYL719 0 3 72 |
HCC70 | Alpelisib | 3 | 72 | 0.001 | 2495.8 | 2855.8 | 517.3 | -3.0 | 0.894 | 0.874 | 2.465 | HCC70 BYL719 0 3 72 |